Navigation Links
Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
Date:9/23/2009

WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- Yesterday the Senate Finance Committee started marking up the America's Healthy Future Act of 2009. The revised version of the bill circulated to the Committee deletes a special provider fee on laboratories and replaces it with an additional $5 billion cut in Medicare Part B payments to clinical laboratories.

The new version of the legislation does not specify how this latest reduction will be allocated. Mark Birenbaum, PhD, the Executive Director of the National Independent Laboratory Association (NILA) and the American Association of Bioanalysts (AAB), says that "If this additional cut is not allocated properly, the reduction will put many community laboratories including those serving nursing home patients, out of business, and give large corporate laboratories that have a small percentage of Medicare Part B work a huge competitive advantage. These large corporate laboratories are the same laboratories that stand to gain from increased enrollment due to health care reform."

Dr. Birenbaum says that the Finance Committee has made a commitment to work with the National Independent Laboratory Association (NILA), and AAB, and others in the laboratory community over the next several weeks to develop an appropriate way to allocate this additional cut to adjust the impact to reflect the amount of Medicare work performed. "The structure of this provision is critical to the future of the community laboratory. It is simply not fair to have the laboratories most involved in Medicare sustain another large cut. They will not survive if some adjustment is not made," says Dr. Birenbaum.

    CONTACT: Stephanie Nagy
    202-207-3637 snagy@prismpublicaffairs.com


'/>"/>
SOURCE National Independent Laboratory Association (NILA)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
2. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
3. ISTO Technologies to Present at OneMedPlace Finance Forum
4. CryoLife to Present at OneMedPlace Finance Forum
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. DRI Capital Launches Structured Finance Fund
7. Wyeth Announces Executive Change in Finance Organization
8. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
9. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
10. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
11. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April ... UTHR ) today announced that its Board of ... of the company,s common stock. This program will became ... 2017. Purchases may be made in the open market, ... time to time as determined by United Therapeutics, management ...
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... ... April 27, 2017 , ... During the ... review how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn ... 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, ...
(Date:4/27/2017)... USA (PRWEB) , ... April 27, 2017 , ... ... optics and photonics , joined other scientists, researchers, engineers, and industry professionals in ... to strengthen America's ability to compete in the world photonics industry. , This ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
Breaking Biology News(10 mins):